Companies
Copalis
EFSA runs multi-year safety testing of bioactive marine peptides before clearing them as Novel Foods, checking allergenic potential and molecular-profile stability, while Copalis (France) supplies specialized wild-fish hydrolysates (Alphamine, Collactive) as a B2B ingredient partner.
- Country
- France
ISO 22000
Coverage
| CN | EU | US | |
|---|---|---|---|
| aquaculture-seafood | ✓ | ✓ | ✓ |
Regulatorsfdaefsanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | 4 million to 4.2 million euros from France Relance plan for a 17 million euro investment program | en.copalis.fr · agroimmo.fr · lagazettefrance.fr · lesechos.fr |
| Capacity | 16,000 tonnes of finished products annually from 55,000 tonnes of co-products, with a goal to increase production volumes by 15% and 30% | en.copalis.fr · lagazettefrance.fr · lesechos.fr · reussir.fr |
| Certification | MarinTrust Standard for Responsible Supply of Marine Ingredients Version 2.0 | marin-trust.com |
| Headcount | Over 100 employees | en.copalis.fr · lagazettefrance.fr · lesechos.fr |
| Revenue | 35 million euros annually | en.copalis.fr · lagazettefrance.fr · lesechos.fr |
| Production site | Le Portel, Boulogne-sur-Mer, France | en.copalis.fr · agroimmo.fr · lagazettefrance.fr · lesechos.fr · reussir.fr |
Independent sources: agroimmo.fr · lagazettefrance.fr · lesechos.fr · marin-trust.com · reussir.fr
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Marine peptides & nutraceuticals | aquaculture-seafood | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.